Nanotransfection-based vasculogenic cell reprogramming drives functional recovery in a mouse model of ischemic stroke

Luke R. Lemmerman, Maria Balch, Jordan Moore, Diego Alzate‐Correa, María A. Rincon‐Benavides, Ana I. Salazar‐Puerta, Surya Gnyawali, Hallie Harris, William Lawrence, Lilibeth Ortega‐Pineda,

Science Advances · 2021 · 53 citations · 38 references

DOIFull text

Open access

Concepts

Abstract

-nanotransfected fibroblasts. Together, our results suggest that vasculogenic cell therapies based on nanotransfection-driven (i.e., nonviral) cellular reprogramming represent a promising strategy for the treatment of ischemic stroke.

References

38